Scilex (SCLX) Revenue & Revenue Breakdown
Scilex Revenue Highlights
Latest Revenue (Y)
$56.59M
Latest Revenue (Q)
$5.00M
Scilex Revenue by Period
Scilex Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $56.59M | 21.07% |
| 2023-12-31 | $46.74M | 22.90% |
| 2022-12-31 | $38.03M | 21.45% |
| 2021-12-31 | $31.32M | 32.92% |
| 2020-12-31 | $23.56M | 12.01% |
| 2019-12-31 | $21.03M | - |
Scilex generated $56.59M in revenue during NA 2024, up 21.07% compared to the previous quarter, and up 269.05% compared to the same period a year ago.
Scilex Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $5.00M | -66.42% |
| 2024-12-31 | $14.90M | 3.21% |
| 2024-09-30 | $14.44M | -11.81% |
| 2024-06-30 | $16.37M | 50.40% |
| 2024-03-31 | $10.88M | -19.15% |
| 2023-12-31 | $13.46M | 33.06% |
| 2023-09-30 | $10.12M | -19.59% |
| 2023-06-30 | $12.58M | 18.90% |
| 2023-03-31 | $10.58M | -11.22% |
| 2022-12-31 | $11.92M | 4.76% |
| 2022-09-30 | $11.38M | 43.54% |
| 2022-06-30 | $7.93M | 16.35% |
| 2022-03-31 | $6.81M | -17.56% |
| 2021-12-31 | $8.26M | -0.71% |
| 2021-09-30 | $8.32M | 6.29% |
| 2021-06-30 | $7.83M | - |
| 2021-03-31 | $7.83M | 32.92% |
| 2020-12-31 | $5.89M | - |
| 2020-09-30 | $5.89M | - |
| 2020-06-30 | $5.89M | - |
| 2020-03-31 | $5.89M | 12.01% |
| 2019-12-31 | $5.26M | - |
| 2019-09-30 | $5.26M | - |
| 2019-06-30 | $5.26M | - |
| 2019-03-31 | $5.26M | - |
Scilex generated $5.00M in revenue during Q1 2025, up -66.42% compared to the previous quarter, and up 37.17% compared to the same period a year ago.
Scilex Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MGNX | MacroGenics | $149.96M | $13.19M |
| ZNTL | Zentalis Pharmaceuticals | $67.42M | - |
| SCLX | Scilex | $56.59M | $5.00M |
| MGX | Metagenomi | $44.76M | $8.51M |
| PRE | Prenetics Global | $21.74M | $6.41M |
| IRD | Opus Genetics | $10.99M | $4.37M |
| SRZN | Surrozen | $10.65M | $983.00K |
| IMDX | Insight Molecular Diagnostics | $1.88M | $518.00K |
| ATYR | aTyr Pharma | $353.00K | - |
| QNCX | Quince Therapeutics | - | - |
| BMEA | Biomea Fusion | - | - |